S&P 500   4,581.64 (-1.58%)
DOW   34,549.99 (-1.67%)
QQQ   392.93 (-1.69%)
AAPL   162.92 (+1.67%)
MSFT   330.44 (-1.84%)
FB   327.95 (-2.98%)
GOOGL   2,856.45 (-1.86%)
AMZN   3,505.67 (-1.57%)
TSLA   1,128.77 (-0.72%)
NVDA   320.56 (-3.95%)
BABA   126.69 (-3.74%)
NIO   38.65 (-4.47%)
CGC   10.34 (-6.51%)
AMD   156.65 (-3.25%)
GE   95.01 (-3.45%)
MU   84.78 (-1.58%)
T   22.60 (-5.40%)
F   19.19 (-2.44%)
DIS   143.47 (-2.94%)
ACB   6.16 (-4.35%)
AMC   33.55 (-8.93%)
PFE   53.73 (+2.54%)
BA   194.36 (-2.09%)
S&P 500   4,581.64 (-1.58%)
DOW   34,549.99 (-1.67%)
QQQ   392.93 (-1.69%)
AAPL   162.92 (+1.67%)
MSFT   330.44 (-1.84%)
FB   327.95 (-2.98%)
GOOGL   2,856.45 (-1.86%)
AMZN   3,505.67 (-1.57%)
TSLA   1,128.77 (-0.72%)
NVDA   320.56 (-3.95%)
BABA   126.69 (-3.74%)
NIO   38.65 (-4.47%)
CGC   10.34 (-6.51%)
AMD   156.65 (-3.25%)
GE   95.01 (-3.45%)
MU   84.78 (-1.58%)
T   22.60 (-5.40%)
F   19.19 (-2.44%)
DIS   143.47 (-2.94%)
ACB   6.16 (-4.35%)
AMC   33.55 (-8.93%)
PFE   53.73 (+2.54%)
BA   194.36 (-2.09%)
S&P 500   4,581.64 (-1.58%)
DOW   34,549.99 (-1.67%)
QQQ   392.93 (-1.69%)
AAPL   162.92 (+1.67%)
MSFT   330.44 (-1.84%)
FB   327.95 (-2.98%)
GOOGL   2,856.45 (-1.86%)
AMZN   3,505.67 (-1.57%)
TSLA   1,128.77 (-0.72%)
NVDA   320.56 (-3.95%)
BABA   126.69 (-3.74%)
NIO   38.65 (-4.47%)
CGC   10.34 (-6.51%)
AMD   156.65 (-3.25%)
GE   95.01 (-3.45%)
MU   84.78 (-1.58%)
T   22.60 (-5.40%)
F   19.19 (-2.44%)
DIS   143.47 (-2.94%)
ACB   6.16 (-4.35%)
AMC   33.55 (-8.93%)
PFE   53.73 (+2.54%)
BA   194.36 (-2.09%)
S&P 500   4,581.64 (-1.58%)
DOW   34,549.99 (-1.67%)
QQQ   392.93 (-1.69%)
AAPL   162.92 (+1.67%)
MSFT   330.44 (-1.84%)
FB   327.95 (-2.98%)
GOOGL   2,856.45 (-1.86%)
AMZN   3,505.67 (-1.57%)
TSLA   1,128.77 (-0.72%)
NVDA   320.56 (-3.95%)
BABA   126.69 (-3.74%)
NIO   38.65 (-4.47%)
CGC   10.34 (-6.51%)
AMD   156.65 (-3.25%)
GE   95.01 (-3.45%)
MU   84.78 (-1.58%)
T   22.60 (-5.40%)
F   19.19 (-2.44%)
DIS   143.47 (-2.94%)
ACB   6.16 (-4.35%)
AMC   33.55 (-8.93%)
PFE   53.73 (+2.54%)
BA   194.36 (-2.09%)
NASDAQ:BFRI

Biofrontera News Headlines

$5.30
-1.80 (-25.35%)
(As of 11/30/2021 12:26 PM ET)
Add
Compare
Today's Range
$5.25
$7.28
50-Day Range
N/A
52-Week Range
$2.25
$10.40
Volume
133,202 shs
Average Volume
17.76 million shs
Market Capitalization
$61.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Media Mentions By Week



Biofrontera Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BFRI
News Sentiment

0.16

0.27

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BFRI Articles
This Week

14

4

BFRI Articles
Average Week

Get Biofrontera News Delivered to You Automatically

Sign up to receive the latest news and ratings for BFRI and its competitors with MarketBeat's FREE daily newsletter.

Biofrontera (NASDAQ:BFRI) News Headlines Today

SourceHeadline
ca.finance.yahoo.com logoBiofrontera Inc. Pricing of $15 Million Private Placement Priced At-the-Market Under Nasdaq Rules
ca.finance.yahoo.com - November 29 at 1:34 PM
nasdaq.com logoBiofrontera Inc Shares Close the Day 51.3% Higher - Daily Wrap
nasdaq.com - November 27 at 6:49 PM
nasdaq.com logoBiofrontera Inc Shares Close the Week 195.9% Higher - Weekly Wrap
nasdaq.com - November 27 at 6:49 PM
markets.businessinsider.com logoMid-Afternoon Market Update: Dow Falls 75 Points; Biofrontera Shares Spike Higher
markets.businessinsider.com - November 24 at 7:32 PM
reuters.com logoBiofrontera Inc
reuters.com - November 24 at 2:32 PM
nasdaq.com logoBiofrontera Continues Rally
nasdaq.com - November 24 at 2:32 PM
MarketBeat logoBiofrontera (BFRI) to Release Quarterly Earnings on Tuesday
americanbankingnews.com - November 24 at 10:33 AM
MarketBeat logoRoth Capital Begins Coverage on Biofrontera (NASDAQ:BFRI)
americanbankingnews.com - November 24 at 8:24 AM
finance.yahoo.com logoBiofrontera Inc. to Report Third Quarter Financial Results on November 30, 2021
finance.yahoo.com - November 24 at 4:31 AM
finance.yahoo.com logoBiofrontera Kicks Off US Clinical Study Program for Ameluz®
finance.yahoo.com - November 16 at 9:25 AM
benzinga.com logoBiofrontera Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Warrants
benzinga.com - November 4 at 2:05 AM
finance.yahoo.com logoBiofrontera Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Warrants
finance.yahoo.com - November 2 at 7:43 PM
finance.yahoo.com logoBiofrontera Inc. Announces Pricing of $18.0 Million Initial Public Offering
finance.yahoo.com - October 29 at 10:03 PM
au.finance.yahoo.com logoIs Biofrontera (NASDAQ:BFRI) In A Good Position To Invest In Growth?
au.finance.yahoo.com - October 29 at 12:02 PM
ca.finance.yahoo.com logoBiofrontera Inc. Announces Pricing of $18.0 Million Initial Public Offering
ca.finance.yahoo.com - October 29 at 12:02 PM
Get Biofrontera News Delivered to You Automatically

Sign up to receive the latest news and ratings for BFRI and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 11/30/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.